Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zin W Myint

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Human Pathology|December 5, 2023
TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?S Emily Bachert, Jing Di, Shengyi Zhang, et al.
Cancers|May 25, 2024
Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional DatabaseCorbin J Eule, Junxiao Hu, Dale Hedges, et al.
Cancers|May 5, 2021
Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic ParametersZin W Myint, Ramon C Sun, Patrick J Hensley, et al.
Therapeutic Advances in Medical Oncology|June 19, 2026
Lineage infidelity in FH-deficient RCC with secondary somatic alterations: a case report and implications for diagnosis and treatmentJianping Zhao, Derek B Allison, Giannicola Genovese, et al.
Cancers|September 9, 2022
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 StudyAlessandro Rizzo, Veronica Mollica, Andrea Marchetti, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 26, 2019
Integrating a 92-Gene Expression Analysis for the Management of Neuroendocrine Tumors of Unknown PrimaryAman Chauhan, Zainab Farooqui, Scott R Silva, et al.
JAMA Network Open|July 9, 2024
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 TrialGeorges Gebrael, Yeonjung Jo, Umang Swami, et al.
Cancers|May 13, 2023
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate CancerZin W Myint, William H St Clair, Stephen E Strup, et al.
Cancers|May 27, 2026
Insulin Pathway Changes in Localized Prostate Cancer: A Multi-Institutional AnalysisEvan R Adler, Anwaruddin Mohammad, Pankaj Kumar, et al.
Clinical Genitourinary Cancer|December 13, 2023
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 StudyFernando Sabino Marques Monteiro, Ondřej Fiala, Francesco Massari, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Human Pathology|December 5, 2023
TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?S Emily Bachert, Jing Di, Shengyi Zhang, et al.
Cancers|May 25, 2024
Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional DatabaseCorbin J Eule, Junxiao Hu, Dale Hedges, et al.
Cancers|May 5, 2021
Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic ParametersZin W Myint, Ramon C Sun, Patrick J Hensley, et al.
Therapeutic Advances in Medical Oncology|June 19, 2026
Lineage infidelity in FH-deficient RCC with secondary somatic alterations: a case report and implications for diagnosis and treatmentJianping Zhao, Derek B Allison, Giannicola Genovese, et al.
Cancers|September 9, 2022
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 StudyAlessandro Rizzo, Veronica Mollica, Andrea Marchetti, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 26, 2019
Integrating a 92-Gene Expression Analysis for the Management of Neuroendocrine Tumors of Unknown PrimaryAman Chauhan, Zainab Farooqui, Scott R Silva, et al.
JAMA Network Open|July 9, 2024
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 TrialGeorges Gebrael, Yeonjung Jo, Umang Swami, et al.
Cancers|May 13, 2023
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate CancerZin W Myint, William H St Clair, Stephen E Strup, et al.
Cancers|May 27, 2026
Insulin Pathway Changes in Localized Prostate Cancer: A Multi-Institutional AnalysisEvan R Adler, Anwaruddin Mohammad, Pankaj Kumar, et al.
Clinical Genitourinary Cancer|December 13, 2023
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 StudyFernando Sabino Marques Monteiro, Ondřej Fiala, Francesco Massari, et al.
Pageof 7